-
Entity
-
Individual
-
Location
-
C/O Centessa Pharmaceuticals Plc, D. Hodgkin Bldg, Babraham Rsrch Campus, Cambridge, United Kingdom
-
Summary
-
The estimated net worth of Aaron Kantoff is at least $1.25M dollars as of August 14, 2024. Aaron Kantoff is the Director of Tourmaline Bio, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $771K. Aaron Kantoff is the Director of Centessa Pharmaceuticals plc and owns shares of Centessa Pharmaceuticals plc (CNTA) stock worth about $478K. Aaron Kantoff is the Director of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $4.93K.